UPDATE - Auriga Initiates Coverage on Henry Schein (HSIC) with a Hold; Long-Term Solid, Near-Term Concerns

April 10, 2012 11:17 AM EDT Send to a Friend
Get Alerts HSIC Hot Sheet
Price: $98.15 +0.52%

Rating Summary:
    2 Buy, 13 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 30
Trade HSIC Now!
UPDATE - Auriga initiates coverage on Henry Schein (Nasdaq: HSIC) with a Hold. PT $73.

Analyst, Glen Losev, said, "Long-term, we view HSIC as a solid investment due to: 1) its position as a vital link within healthcare industry chain; 2) its market share position and our view that HSIC will continue to cement its footprint as a distributor of choice to dental, medical and veterinary providers; 3) the aging of baby boomers driving demand for preventive care in the US in dental and medical fields, and 4) a focused and capable management team. Near-term, however, we cannot recommend shares of HSIC due to: 1) current valuation levels and recent shares appreciation; 2) Euro-zone debt crisis; 3) slowdown in global economy. These factors keep us on the sidelines at this time."

To see more ratings on HSIC, Click Here



Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Auriga

Add Your Comment